Analgesics is set to see slow retail current value growth in New Zealand in 2024. During the period 2020-2021, the government’s response to the COVID-19 pandemic included movement restrictions and reduced levels of social interaction, which meant that incidences of seasonal cold and flu reduced year-over-year, which should have had a negative impact on sales of analgesics. Nevertheless, demand was instead driven by demand to relieve the symptoms of COVID-19.
The Analgesics in New Zealand report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.
The Analgesics in New Zealand report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Analgesics market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
KEY DATA FINDINGSCONSUMER HEALTH IN NEW ZEALANDDISCLAIMERDEFINITIONS
2024 DEVELOPMENTS
PROSPECTS AND OPPORTUNITIES
CATEGORY DATA
EXECUTIVE SUMMARY
MARKET INDICATORS
MARKET DATA
APPENDIX
SOURCES
